DRD2 and schizophrenia: Thus, both typical and atypical antipsychotic drugs are thought to diminish the positive symptoms of schizophrenia by antagonizing dopamine D2 receptors within the mesolimbic dopamine system, a projection which originates in the mid brain and terminates in the nucleus accumbens and amygdala [6].